ALIDABRAFENIB
- Strength
- 75mg
- Manufacturer
- Availability
- Available to source
Ask for price
Dabrafenib mesylate 75mg
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Dabrafenib is a kinase inhibitor that may be used alone or in combination with trametinib. It is indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600 mutation, for the adjuvant treatment of BRAF V600-mutant melanoma after surgery, and for the treatment of metastatic non-small cell lung cancer with a BRAF V600E mutation.
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
Related medicines
